| +0.105 / +1.14%|
The 2 analysts offering 12-month price forecasts for Symmetry Medical Inc have a median target of 11.75, with a high estimate of 12.00 and a low estimate of 11.50. The median estimate represents a +26.41% increase from the last price of 9.30.
The current consensus among 3 polled investment analysts is to Buy stock in Symmetry Medical Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.